Drug Profile
Pyripyropene B
Latest Information Update: 20 Jul 1998
Price :
$50
*
At a glance
- Originator Kitasato Institute
- Class Antihyperlipidaemics; Pyridines; Sesquiterpenes
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 20 Jul 1998 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)
- 17 Mar 1995 Preclinical development for Hypercholesterolaemia in Japan (Unknown route)